创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

李宏源, 王昆淼, 夭建华, 刘志华, 朱海洲, 王晓辉. 尼古丁的药物转化研究进展[J]. 药学进展, 2019, 43(1): 34-41.
引用本文: 李宏源, 王昆淼, 夭建华, 刘志华, 朱海洲, 王晓辉. 尼古丁的药物转化研究进展[J]. 药学进展, 2019, 43(1): 34-41.
LI Hongyuan, WANG Kunmiao, YAO Jianhua, LIU Zhihua, ZHU Haizhou, WANG Xiaohui. Research Progress in the Development of Nicotine as a Medicine[J]. Progress in Pharmaceutical Sciences, 2019, 43(1): 34-41.
Citation: LI Hongyuan, WANG Kunmiao, YAO Jianhua, LIU Zhihua, ZHU Haizhou, WANG Xiaohui. Research Progress in the Development of Nicotine as a Medicine[J]. Progress in Pharmaceutical Sciences, 2019, 43(1): 34-41.

尼古丁的药物转化研究进展

Research Progress in the Development of Nicotine as a Medicine

  • 摘要: 吸烟过程中产生的大部分化学物质严重危害人类生命健康。尼古丁是造成吸烟成瘾的主要物质,其可以迅速穿透血脑屏障,对神经系统产生多方面的作用。近年来,尼古丁被发现具有药物转化开发价值。流行病学统计显示,吸烟人群中某些重大疾病发生的比例远低于不吸烟的人群, 其中包括炎症性疾病及多种神经退行性疾病。对相关疾病发生发展过程中尼古丁所起的抑制炎症和神经保护的作用进行探讨,将为尼古丁的转化应用提供重要理论依据。

     

    Abstract: Most of the various chemicals produced during smoking are harmful to health. Nicotine, the major substance that leads to smoking addiction, can easily penetrate blood-brain-barrier and produce various effects on the nervous system. In recent years, it has been discovered that nicotine has the potential to be developed into a medicine. Epidemiological studies have shown that the incidence of some major diseases including inflammation and neurodegenerative diseases in smokers is much lower than in non-smokers. This paper discussed the anti-inflammatory and neuroprotective effects of nicotine in the pathogenesis and progression of some diseases, providing important theoretical evidence for the development of nicotine into medicine.

     

/

返回文章
返回